Neuron23 Competitors and Similar CompaniesClear all
Neuron23's competitors and similar companies include Algenex, SpliceBio, Sarepta Therapeutics and Bluebird Bio.
 Algenex Algenex is a biotechnology company developing technologies to support the production of recombinant proteins using Baculovirus vector expression systems (BVES) in insect cells. |  SpliceBio SpliceBio (formerly known as ProteoDesign) is a biotechnology company developing gene therapies. |  Sarepta Therapeutics Sarepta Therapeutics is a biopharmaceutical company specializing in the discovery and development of RNA-targeted therapeutics, gene therapy and, other genetic therapeutic modalities for the treatment of rare diseases. | |||
Founding Date | Founding Date 2018 | Founding Date 2005 | Founding Date 2012 | Founding Date 1980 | Founding Date 1992 |
Type | Type Private | Type Private | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations South San Francisco, US HQ | Locations Madrid, ES HQ | Locations Barcelona, ES HQ | Locations Cambridge, US HQ Dublin, IE Zug, CH Providence, US | Locations Somerville, US HQ |
Employees | Employees 427% decrease | Employees 403% increase | Employees 452% decrease | Employees 1,31413% increase | Employees 32338% decrease |
Valuation ($) | Valuation ($) 507.1 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 12.4 b | Valuation ($) 95.4 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $2.2b (FY, 2025) | Revenue (est.) $83.8m (FY, 2024) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods $25.5m (FY, 2025) | Cost of goods $89.4m (FY, 2024) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit N/A | Gross profit $2.2b (FY, 2025) | Gross profit ($5.6m) (FY, 2024) |
Net income | Net income N/A | Net income N/A | Net income N/A | Net income ($713.4m) (FY, 2025) | Net income ($240.7m) (FY, 2024) |
Funding | |||||
Latest funding round | Latest funding round $ 80m (over 5 years ago) | Latest funding round N/A | Latest funding round $ 2m (about 8 years ago) | Latest funding round N/A | Latest funding round N/A |
Total funding raised | Total funding raised $ 113.5m | Total funding raised N/A | Total funding raised $ 2m | Total funding raised N/A | Total funding raised $ 409m |
For sources of this data, please see the company profile
View Company Profiles
Algenex
HQ
Madrid, ES
Employees
40↑ 3% increase
Algenex is a biotechnology company developing technologies to support the production of recombinant proteins using Baculovirus vector expression systems (BVES) in insect cells.
View companySpliceBio
HQ
Barcelona, ES
Employees
45↓ 2% decrease
SpliceBio (formerly known as ProteoDesign) is a biotechnology company developing gene therapies.
View companySarepta Therapeutics
HQ
Cambridge, US
Employees
1,314↑ 13% increase
Sarepta Therapeutics is a biopharmaceutical company specializing in the discovery and development of RNA-targeted therapeutics, gene therapy and, other genetic therapeutic modalities for the treatment of rare diseases.
View company
Bluebird Bio
HQ
Somerville, US
Employees
323↓ 38% decrease
Bluebird Bio is a developer of gene therapies for severe genetic diseases.
View company